+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Intravenous Immunoglobulin - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Intravenous Immunoglobulin - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Adenosine Deaminase-Severe Combined Immunodeficiency - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Adenosine Deaminase-Severe Combined Immunodeficiency - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Wiskott-aldrich Syndrome - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Wiskott-aldrich Syndrome - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Celiac Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Celiac Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Allergy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Allergy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 125 Pages
  • Global
From
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • November 2024
  • 145 Pages
  • Global
From
Endometriosis - Pipeline Insight, 2024 - Product Thumbnail Image

Endometriosis - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Allergic Rhinitis - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Allergic Rhinitis - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
Inclusion Body Myositis - Pipeline Insight, 2025 - Product Thumbnail Image

Inclusion Body Myositis - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 60 Pages
  • Global
From
Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2025
  • 308 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Hizentra Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Hizentra Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 240 Pages
  • Global
From
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 67 Pages
  • Global
From
Peanut Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2024 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more